I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Marie-Helene Delfau-Larue
149
results:
Search for persons
X
Format
Online (149)
Mediatypes
Articles (Online) (55)
OpenAccess-fulltext (94)
Sorted by: Year
Sorted by: Relevance
?
1
Author Correction: Axicabtagene ciloleucel as second-line t..:
Houot, Roch
;
Bachy, Emmanuel
;
Cartron, Guillaume
...
Nature Medicine. , 2024
Link:
https://doi.org/10.1038/..
?
2
Oral azacitidine compared with standard therapy in patients..:
Dupuis, Jehan
;
Bachy, Emmanuel
;
Morschhauser, Franck
...
The Lancet Haematology. 11 (2024) 6 - p. e406-e414 , 2024
Link:
https://doi.org/10.1016/..
?
3
Tumor necrosis factor receptor type 2 (TNFR2) may represent..:
Beldi-Ferchiou, Asma
;
Saskia, Oro
;
Molinier-Frenkel, Valérie
...
European Journal of Cancer. 190 (2023) - p. 112989 , 2023
Link:
https://doi.org/10.1016/..
?
4
S233: AXICABTAGENE CILOLEUCEL AS SECOND-LINE THERAPY FOR LA..:
Houot, Roch
;
Bachy, Emmanuel
;
Cartron, Guillaume
...
HemaSphere. 7 (2023) S3 - p. e56791ba , 2023
Link:
https://doi.org/10.1097/..
?
5
Publisher Correction: Axicabtagene ciloleucel as second-lin..:
Houot, Roch
;
Bachy, Emmanuel
;
Cartron, Guillaume
...
Nature Medicine. 29 (2023) 10 - p. 2665-2665 , 2023
Link:
https://doi.org/10.1038/..
?
6
P1123: EARLY CTDNA CLEARANCE AFTER CAR T-CELL INFUSION PRED..:
Delfau-Larue, Marie-Helene
;
Gomes, Lucie
;
Cartron, Guillaume
...
HemaSphere. 7 (2023) S3 - p. e5262795 , 2023
Link:
https://doi.org/10.1097/..
?
7
Axicabtagene ciloleucel as second-line therapy in large B c..:
Houot, Roch
;
Bachy, Emmanuel
;
Cartron, Guillaume
...
Nature Medicine. 29 (2023) 10 - p. 2593-2601 , 2023
Link:
https://doi.org/10.1038/..
?
8
P1224: PATIENT-DERIVED XENOGRAFT (PDX) IS A USEFUL TOOL FOR..:
Tari, Gamze
;
Sako, Nouhoum
;
Robe, Cyrielle
...
HemaSphere. 7 (2023) S3 - p. e89980e8 , 2023
Link:
https://doi.org/10.1097/..
?
9
S238: CLONAL ARCHITECTURE OF RELAPSED OR REFRACTORY ANGIOIM..:
Loyaux, Romain
;
Sako, Nouhoum
;
Quang, Violaine Tran
...
HemaSphere. 7 (2023) S3 - p. e1859693 , 2023
Link:
https://doi.org/10.1097/..
?
10
S238: CLONAL ARCHITECTURE OF RELAPSED OR REFRACTORY ANGIOIM..:
Romain Loyaux
;
Nouhoum Sako
;
Violaine Tran Quang
...
http://journals.lww.com/10.1097/01.HS9.0000967864.18596.93. , 2023
Link:
https://doi.org/10.1097/..
?
11
P1123: EARLY CTDNA CLEARANCE AFTER CAR T-CELL INFUSION PRED..:
Delfau-Larue, Marie-Helene
;
Gomes, Lucie
;
Cartron, Guillaume
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430960/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
12
S233: AXICABTAGENE CILOLEUCEL AS SECOND-LINE THERAPY FOR LA..:
Houot, Roch
;
Bachy, Emmanuel
;
Cartron, Guillaume
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428382/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
13
S238: CLONAL ARCHITECTURE OF RELAPSED OR REFRACTORY ANGIOIM..:
Loyaux, Romain
;
Sako, Nouhoum
;
Quang, Violaine Tran
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428380/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
14
P1123: EARLY CTDNA CLEARANCE AFTER CAR T-CELL INFUSION PRED..:
Marie-Helene Delfau-Larue
;
Lucie Gomes
;
Guillaume Cartron
...
http://journals.lww.com/10.1097/01.HS9.0000971388.52627.95. , 2023
Link:
https://doi.org/10.1097/..
?
15
S233: AXICABTAGENE CILOLEUCEL AS SECOND-LINE THERAPY FOR LA..:
Roch Houot
;
Emmanuel Bachy
;
Guillaume Cartron
...
http://journals.lww.com/10.1097/01.HS9.0000967844.56791.ba. , 2023
Link:
https://doi.org/10.1097/..
1-15
